Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HealthLynked (HLYK) EBIT (2016 - 2025)

Historic EBIT for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to -$736654.0.

  • HealthLynked's EBIT rose 5592.45% to -$736654.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year increase of 3851.29%. This contributed to the annual value of -$4.7 million for FY2024, which is 1266.8% down from last year.
  • According to the latest figures from Q3 2025, HealthLynked's EBIT is -$736654.0, which was up 5592.45% from -$682780.0 recorded in Q2 2025.
  • Over the past 5 years, HealthLynked's EBIT peaked at -$490310.0 during Q3 2021, and registered a low of -$4.1 million during Q4 2022.
  • Its 5-year average for EBIT is -$1.3 million, with a median of -$1.2 million in 2024.
  • Its EBIT has fluctuated over the past 5 years, first tumbled by 21243.46% in 2022, then skyrocketed by 7319.87% in 2023.
  • HealthLynked's EBIT (Quarter) stood at -$1.9 million in 2021, then crashed by 123.34% to -$4.1 million in 2022, then skyrocketed by 73.2% to -$1.1 million in 2023, then soared by 32.67% to -$748774.0 in 2024, then rose by 1.62% to -$736654.0 in 2025.
  • Its last three reported values are -$736654.0 in Q3 2025, -$682780.0 for Q2 2025, and -$931365.0 during Q1 2025.